SUN Pharmaceutical Industries Limited — Cefpodoxime Exporter Profile
Indian Pharmaceutical Exporter · #5 for Cefpodoxime · $1.6M export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #5 Indian exporter of Cefpodoxime with $1.6M in export value and 32 verified shipments. SUN Pharmaceutical Industries Limited holds a 2.0% market share in Cefpodoxime exports across 4 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Cefpodoxime Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Cefpodoxime?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BELGIUM | $680.2K | 20 | 60.1% |
| SOUTH AFRICA | $182.6K | 5 | 16.1% |
| FRANCE | $169.7K | 5 | 15.0% |
| UNITED ARAB EMIRATES | $100.0K | 2 | 8.8% |
SUN Pharmaceutical Industries Limited exports Cefpodoxime to 4 countries. The largest destination is BELGIUM accounting for 60.1% of SUN Pharmaceutical Industries Limited's Cefpodoxime shipments, followed by SOUTH AFRICA (16.1%) and FRANCE (15.0%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cefpodoxime from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $432.4K | 14 |
| YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN | BELGIUM | $155.1K | 4 |
| M/S. PLANET PHARMA | FRANCE | $100.0K | 2 |
| M S YUSEN LOGISTICS BENELUX BELGIU MKEETBERGLAAN | BELGIUM | $92.7K | 2 |
| RANBAXY SOUTH AFRICA PTY LIMITED | SOUTH AFRICA | $87.6K | 2 |
| MS PLANET PHARMA SAAU CAPITAL | FRANCE | $69.7K | 3 |
| MS GIGI MEDICAL STORE LLC | UNITED ARAB EMIRATES | $50.0K | 1 |
| M S RANBAXY SOUTH AFRICA PTY LIMITED | SOUTH AFRICA | $50.0K | 1 |
| M/S. GIGI MEDICAL STORE LLC , | UNITED ARAB EMIRATES | $50.0K | 1 |
| M/S. RANBAXY PHARMACEUTICALS PTY LT | SOUTH AFRICA | $23.1K | 1 |
SUN Pharmaceutical Industries Limited supplies Cefpodoxime to 11 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN (BELGIUM) and M/S. PLANET PHARMA (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cefpodoxime Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $33.7M worth of Cefpodoxime through 1,734 shipments from 178 suppliers to 78 countries, serving 442 buyers globally. SUN Pharmaceutical Industries Limited contributes $1.6M to this total, accounting for 2.0% of India's Cefpodoxime exports. SUN Pharmaceutical Industries Limited ships Cefpodoxime to 4 countries through 11 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Cefpodoxime Exports?
SUN Pharmaceutical Industries Limited's average Cefpodoxime shipment value is $50.0K per consignment, based on 32 shipments totaling $1.6M. The largest destination is BELGIUM (60.1% of SUN Pharmaceutical Industries Limited's Cefpodoxime exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Cefpodoxime Exporters?
SUN Pharmaceutical Industries Limited ranks #5 among 178 Indian Cefpodoxime exporters with a 2.0% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($10.9M), LUPIN LIMITED ($10.6M), AUROBINDO PHARMA LIMITED ($4.5M). SUN Pharmaceutical Industries Limited processed 32 shipments to 4 destination countries.
What Cefpodoxime Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CEFPO BASICS TABLETS 200MG PACK : 4X5 (S05) BATCH : DFF1684B, DFF1685A EACH FILMCOATED TAB CONTS: CEFPODOXIME PROXETIL | $146.6K | 3 |
| CEFPO BASICS TABLETS 200MG PACK : 3X5 BATCH : DFF1686A EACH FILM COATED TAB CONTS: CEFPODOXIME PROXETIL EQ TO CEFPODOXIM | $92.5K | 3 |
| CEPODEM TAB 200MG PACK:10s STRIP BATCH:3207007 EACH FILM COATED TAB CONTS.CEFPODOXIME PROXETIL USP EQ TO CEFPODOXIME 200 | $69.7K | 3 |
| CEFPO BASICS TABLETS 200MG PACK : 2X5 STRIP BATCH : DFF0161A EACH FILM COATED TAB CONTS: CEFPODOXIME PROXETIL EQ TO CEFP | $58.5K | 3 |
| CEFPO BASICS TABLETS 200MG PACK : 4x5 S05 Batch : DFE2291B EACH FILM COATED TAB CONTS: CEFPODOXIME PROXETIL EQ TO CEF | $50.0K | 1 |
| CEPODEM TABLETS 200MG PACK: 10s Strip BATCH: DFE3221A EACH TABLET CONT.: CEFPODOXIME PROXETIL EQ. TO 200MG | $50.0K | 1 |
| CEPODEM TAB 200MG APCK:10S STRIP BATCH:DFE4530A DFE4531A EACH FILM COATED TAB CONTS. CEFPODOXIME PROXETIL USP EQ TO CEF | $50.0K | 1 |
| CEFPO BASICS TABLETS 200MG PACK: Box2x5sBATCH: DFE6009A EACH FILM COATED TABLETCONT.: CEFPODOXIME PROXETIL EQ. TO CEFP | $50.0K | 1 |
| CEFPO BASICS TABLETS 200MG PACK: 4x5 S05 BATCH: DFE6008BEACH FILM COATED TAB CONT.: CEFPODOXIME PROXETIL EQ. TO CEFPO | $50.0K | 1 |
| CEPODEM TAB 200MG PACK:10s STRIP BATCH:DFE6575A DFE6576A EACH FILM COATED TAB CONTS CEFPODOXIME PROXETIL USP EQ TO CEFP | $50.0K | 1 |
SUN Pharmaceutical Industries Limited exports 22 distinct Cefpodoxime formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CEFPO BASICS TABLETS 200MG PACK : 4X5 (S05) BATCH : DFF1684B with 3 shipments worth $146.6K.
Regulatory Requirements: Exporting Cefpodoxime to Key Markets
What SUN Pharmaceutical Industries Limited must comply with to export Cefpodoxime to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Cefpodoxime Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | LUPIN LIMITED | $10.6M | 297 | 9 | $35.7K |
| 4 | AUROBINDO PHARMA LIMITED | $4.5M | 89 | 10 | $50.0K |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $1.6M | 32 | 4 | $50.0K |
| 1 | ALKEM LABORATORIES LIMITED | $1.4M | 29 | 5 | $50.0K |
| 7 | MICRO LABS LIMITED | $696.4K | 30 | 3 | $23.2K |
SUN Pharmaceutical Industries Limited ranks #5 among 178 Indian Cefpodoxime exporters. Average shipment value of $50.0K compared to the market average of $189.3K. The closest competitors by value are LUPIN LIMITED and AUROBINDO PHARMA LIMITED.
Which Indian Ports Ship Cefpodoxime Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 174 | 10.0% |
| SAHAR AIR | 166 | 9.6% |
| JNPT/ NHAVA SHEVA SEA | 133 | 7.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 128 | 7.4% |
| JNPT | 88 | 5.1% |
| DELHI AIR | 81 | 4.7% |
| HYDERABAD ICD | 79 | 4.6% |
| DELHI AIR CARGO ACC (INDEL4) | 78 | 4.5% |
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Cefpodoxime Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Cefpodoxime, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cefpodoxime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cefpodoxime shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 32 individual customs records matching SUN Pharmaceutical Industries Limited exporting Cefpodoxime, covering 22 formulations to 4 countries via 11 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 78+ countries, 442+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cefpodoxime Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Cefpodoxime exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Cefpodoxime Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefpodoxime. For current shipment-level data, contact TransData Nexus.